Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer
- People aged between 18 and 45 years old (this applies to the PREFER-FERTILITY part of the trial only)
- People who have not yet received any radiation or chemotherapy treatment for their cancer before joining (PREFER-FERTILITY part only)
- People whose breast cancer has not spread to other parts of the body (PREFER-FERTILITY part only)
- People who were diagnosed with breast cancer during pregnancy, within one year after the end of a pregnancy, or who became pregnant after already being diagnosed and treated for breast cancer (this applies to the PREFER-PREGNANCY part of the trial only)
- People who are able to give written informed consent to participate
Who may not be able to join:
- People who are unable to provide written consent to participate in the trial
- People whose breast cancer had already spread to distant parts of the body (stage IV) at the time of diagnosis (PREFER-FERTILITY part only)
- People who have serious psychiatric (mental health) disorders
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390105558908
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of patients interested in the available strategies for fertility preservation; Rate of patients undergoing the different strategies for fertility preservation; Type of strategies for fertility preservation proposed by oncologists; Reasons for refusal of the available strategies for fertility preservation; Type of anticancer therapies administered during pregnancy; Safety: pregnancy complications; Safety: incidence of adverse events; Disease-free survival; Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.